Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders.
Walid Abi HabibFréderic BrioudeSalah AzziSylvie RossignolAgnès LinglartMarie-Laure SobrierEloïse GiabicaniVirginie SteunouMadeleine D HarbisonYves Le BoucIrène NetchinePublished in: Science advances (2019)
Imprinting disorders (IDs) often affect growth in humans, leading to diseases with overlapping features, regardless of the genomic region affected. IDs related to hypomethylation of the human 14q32.2 region and its DLK1/MEG3 domain are associated with Temple syndrome (TS14). TS14 is a rare type of growth retardation, the clinical signs of which overlap considerably with those of Silver-Russell syndrome (SRS), another ID related to IGF2 down-regulation at 11p15.5 region. We show that 14q32.2 hypomethylation affects expression, not only for genes at this locus but also for other imprinted genes, and especially lowers IGF2 levels at 11p15.5. Furthermore, expression of nonimprinted genes is also affected, some of which are also deregulated in SRS patients. These findings highlight the epigenetic regulation of gene expression at the DLK1/MEG3 domain. Expression profiling of TS14 and SRS patients highlights common signatures, which may account for the clinical overlap observed between TS14 and SRS.
Keyphrases
- gene expression
- end stage renal disease
- genome wide
- ejection fraction
- chronic kidney disease
- binding protein
- prognostic factors
- dna methylation
- peritoneal dialysis
- gold nanoparticles
- case report
- oxidative stress
- patient reported outcomes
- mass spectrometry
- patient reported
- pi k akt
- heat shock
- induced pluripotent stem cells
- growth hormone
- tandem mass spectrometry